Literature DB >> 3091062

Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin).

K Dalziel, G Going, P H Cartwright, R Marks, G W Beveridge, N R Rowell.   

Abstract

Twenty-three patients with severe longstanding discoid lupus erythematosus, unresponsive to conventional treatments, were treated with oral gold in a multicentre open study. Nineteen patients showed clinical improvement and in four of these there was complete resolution of lesions. Adverse reactions were generally mild and self limiting.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091062     DOI: 10.1111/j.1365-2133.1986.tb05720.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

Review 1.  Drug-induced "allergic hepatitis".

Authors:  P Podevin; M Biour
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 2.  Gold-based therapy: From past to present.

Authors:  Alice Balfourier; Jelena Kolosnjaj-Tabi; Nathalie Luciani; Florent Carn; Florence Gazeau
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

Review 3.  Drugs for discoid lupus erythematosus.

Authors:  Sue Jessop; David A Whitelaw; Matthew J Grainge; Prativa Jayasekera
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

4.  Gold nanoparticles: a revival in precious metal administration to patients.

Authors:  A S Thakor; J Jokerst; C Zavaleta; T F Massoud; S S Gambhir
Journal:  Nano Lett       Date:  2011-09-07       Impact factor: 11.189

5.  Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome.

Authors:  Gabsik Yang; Seon Joo Lee; Han Chang Kang; Yong-Yeon Cho; Hye Suk Lee; Christos C Zouboulis; Sin-Hee Han; Kyung-Ho Ma; Jae-Ki Jang; Joo Young Lee
Journal:  Biomol Ther (Seoul)       Date:  2020-09-01       Impact factor: 4.634

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.